• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells" [Canc. Lett. 403 (2017) 260-270].

作者信息

Fu Hui, He Yuchao, Qi Lisha, Chen Lu, Luo Yi, Chen Liwei, Li Yongmei, Zhang Ning, Guo Hua

机构信息

Department of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China; The Key Laboratory of Tianjin Cancer Prevention and Treatment, National Clinical Research Center for Cancer, Tianjin, 300060, China; Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, China.

Department of Tumor Cell Biology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300060, China; The Key Laboratory of Tianjin Cancer Prevention and Treatment, National Clinical Research Center for Cancer, Tianjin, 300060, China.

出版信息

Cancer Lett. 2021 Feb 1;498:240-241. doi: 10.1016/j.canlet.2020.11.009. Epub 2020 Nov 19.

DOI:10.1016/j.canlet.2020.11.009
PMID:33221059
Abstract
摘要

相似文献

1
Corrigendum to "cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells" [Canc. Lett. 403 (2017) 260-270].《“cPLA2α在肝癌细胞上皮-间质转化过程中激活PI3K/AKT并抑制Smad2/3”的勘误》[《癌症快报》403卷（2017年）260 - 270页]
Cancer Lett. 2021 Feb 1;498:240-241. doi: 10.1016/j.canlet.2020.11.009. Epub 2020 Nov 19.
2
cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells.在肝癌细胞上皮-间质转化过程中，胞质型磷脂酶A2α（cPLA2α）激活磷脂酰肌醇-3激酶/蛋白激酶B（PI3K/AKT）并抑制Smad2/3。
Cancer Lett. 2017 Sep 10;403:260-270. doi: 10.1016/j.canlet.2017.06.022. Epub 2017 Jun 23.
3
Corrigendum to "Long non-coding RNA Unigene 56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells" [Canc. Lett. 382 (2016) 166-175].《“长链非编码RNA Unigene 56159通过作为肝细胞癌细胞中miR-140-5p的ceRNA促进上皮-间质转化”的勘误》[《癌症快报》382 (2016) 166 - 175]
Cancer Lett. 2020 Mar 1;472:181-182. doi: 10.1016/j.canlet.2019.12.021. Epub 2019 Dec 24.
4
Corrigendum to "MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways" [Canc. Lett. 337 (2013) 226-236].《“MicroRNA-21通过AKT/ERK途径抑制PTEN和hSulf-1表达并促进肝细胞癌进展”的勘误》[《癌症快报》337 (2013) 226 - 236]
Cancer Lett. 2020 Mar 31;473:198-199. doi: 10.1016/j.canlet.2019.12.034. Epub 2020 Jan 8.
5
Corrigendum to "FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer" [Canc. Lett. 397 (2017) 83-93].《“FAT1通过MAPK/ERK信号通路抑制食管鳞状细胞癌上皮-间质转化（EMT）”的勘误》[《癌症通讯》397（2017）83 - 93]
Cancer Lett. 2020 Dec 1;494:1-2. doi: 10.1016/j.canlet.2020.07.038. Epub 2020 Aug 17.
6
Saponins from the roots of Platycodon grandiflorum suppresses TGFβ1-induced epithelial-mesenchymal transition via repression of PI3K/Akt, ERK1/2 and Smad2/3 pathway in human lung carcinoma A549 cells.桔梗根中的皂苷通过抑制人肺癌 A549 细胞中的 PI3K/Akt、ERK1/2 和 Smad2/3 通路抑制 TGFβ1 诱导的上皮-间充质转化。
Nutr Cancer. 2014;66(1):140-51. doi: 10.1080/01635581.2014.853087. Epub 2013 Dec 16.
7
cPLA2α mediates TGF-β-induced epithelial-mesenchymal transition in breast cancer through PI3k/Akt signaling.胞质型磷脂酶A2α（cPLA2α）通过PI3k/Akt信号通路介导转化生长因子-β（TGF-β）诱导的乳腺癌上皮-间质转化。
Cell Death Dis. 2017 Apr 6;8(4):e2728. doi: 10.1038/cddis.2017.152.
8
Corrigendum to "miR-371-5p down-regulates pre mRNA processing factor 4 homolog B (PRPF4B) and facilitates the G1/S transition in human hepatocellular carcinoma" [Canc. Lett. 335 (2013) 351-360].《“miR-371-5p下调前体mRNA加工因子4同源物B（PRPF4B）并促进人肝细胞癌的G1/S期转换”的勘误》[《癌症快报》335卷（2013年）第351 - 360页]
Cancer Lett. 2021 May 1;505:87-90. doi: 10.1016/j.canlet.2021.02.015. Epub 2021 Mar 5.
9
Corrigendum to "UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation" [Canc. Lett. 494 (2020) 121-131].对“UBE2T通过诱导上皮-间质转化和泛素化介导的FOXO1降解促进非小细胞肺癌的辐射抗性”的勘误 [《癌症快报》494 (2020) 121-131]。
Cancer Lett. 2022 Sep 1;543:215792. doi: 10.1016/j.canlet.2022.215792. Epub 2022 Jun 17.
10
Corrigendum to "LncRNA n335586/miR-924/CKMT1A axis contributes to cell migration and invasion in hepatocellular carcinoma cells" [Canc. Lett. 429 (2018) 89-99].《“LncRNA n335586/miR-924/CKMT1A轴促进肝癌细胞的迁移和侵袭”的勘误》[《癌症快报》429 (2018) 89 - 99]
Cancer Lett. 2020 Dec 1;494:84-87. doi: 10.1016/j.canlet.2020.07.018. Epub 2020 Sep 7.